Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Tratamiento con hierro para la anemia preoperatoria

Esta versión no es la más reciente

ver la versión actual 07 diciembre 2019

Información

DOI:
https://doi.org/10.1002/14651858.CD011588.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 22 diciembre 2015see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Lesiones

Copyright:
  1. Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Oliver Ng

    Correspondencia a: Nottingham Digestive Disease Centre, E Floor West Block, Nottingham, UK

    [email protected]

  • Barrie D Keeler

    Division of GI Surgery, School of Clinical Sciences, University of Nottingham, Nottingham, UK

  • Amitabh Mishra

    Department of GI Surgery, School of Clinical Sciences, Nottingham University Hospitals NHS Trust, Nottingham, UK

  • Alastair Simpson

    Department of GI Surgery, School of Clinical Sciences, Nottingham University Hospitals NHS Trust, Nottingham, UK

  • Keith Neal

    Department of Epidemiology and Public Health, University of Nottingham, Derby, UK

  • Matthew J Brookes

    Gastroenterology Unit, Royal Wolverhampton NHS Trust, Wolverhampton, UK

  • Austin G Acheson

    Division of Gastrointestinal Surgery, Nottingham University Hospital Queen's Medical Centre, Nottingham, UK

Contributions of authors

AM, BK, AS: Main contribution to the study concepts and study design.

ON, BK: Main contribution to the data acquisition, analysis, interpretation and manuscript preparation.

KN: Main contribution to statistical support.

MB, AA: Main contribution to supervision and revision of the manuscript.

Declarations of interest

Ng O: I have received honoraria and travel support for consulting from Pharmacosmos A/S.

Keeler B: None known.

Mishra A: None known.

Simpson A: None known.

Neal K: None known.

Brookes MJ: My research department has received grant support from Syner‐Med and Vifor Pharma. I have received honoraria and travel support for consulting or lecturing from Vifor Pharma and Merck Sharp.

Acheson AG: My research department has received grant support from Syner‐Med, Vifor Pharma and Pharmacosmos A/S. I have received honoraria and travel support for consulting or lecturing from Ethicon Endosurgery, Johnson and Johnson Ltd, Olympus and Vifor Pharma.

Acknowledgements

The authors would like to thank Dr George Dowswell and Dr Shu Li Ng for their support and guidance in the protocol design.

This project was supported by the UK National Institute for Health Research, through Cochrane Infrastructure funding to the Cochrane Injuries Group. The views and opinions expressed are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.

Version history

Published

Title

Stage

Authors

Version

2019 Dec 07

Iron therapy for preoperative anaemia

Review

Oliver Ng, Barrie D Keeler, Amitabh Mishra, J A Simpson, Keith Neal, Hafid Omar Al‐Hassi, Matthew J Brookes, Austin G Acheson

https://doi.org/10.1002/14651858.CD011588.pub3

2015 Dec 22

Iron therapy for pre‐operative anaemia

Review

Oliver Ng, Barrie D Keeler, Amitabh Mishra, Alastair Simpson, Keith Neal, Matthew J Brookes, Austin G Acheson

https://doi.org/10.1002/14651858.CD011588.pub2

2015 Apr 02

Iron therapy for pre‐operative anaemia

Protocol

Oliver Ng, Barrie Keeler, Amitabh Mishra, Alastair Simpson, Keith Neal, Matthew J Brookes, Austin G Acheson

https://doi.org/10.1002/14651858.CD011588

Keywords

MeSH

Medical Subject Headings (MeSH) Keywords

Medical Subject Headings Check Words

Humans;

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.

Study flow diagram.
Figuras y tablas -
Figure 1

Study flow diagram.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. Three studies are included in this review.
Figuras y tablas -
Figure 2

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. Three studies are included in this review.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
Figuras y tablas -
Figure 3

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Comparison 1 Iron therapy versus placebo or no iron therapy, Outcome 1 Proportion of patients who received a blood transfusion.
Figuras y tablas -
Analysis 1.1

Comparison 1 Iron therapy versus placebo or no iron therapy, Outcome 1 Proportion of patients who received a blood transfusion.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Comparison 1 Iron therapy versus placebo or no iron therapy, Outcome 2 Haemoglobin levels pre‐treatment (g/dL).
Figuras y tablas -
Analysis 1.2

Comparison 1 Iron therapy versus placebo or no iron therapy, Outcome 2 Haemoglobin levels pre‐treatment (g/dL).

Ir a la figura de la revisiónAbrir en una pestaña nueva

Comparison 1 Iron therapy versus placebo or no iron therapy, Outcome 3 Haemoglobin levels at end of treatment pre‐op (g/dL).
Figuras y tablas -
Analysis 1.3

Comparison 1 Iron therapy versus placebo or no iron therapy, Outcome 3 Haemoglobin levels at end of treatment pre‐op (g/dL).

Ir a la figura de la revisiónAbrir en una pestaña nueva

Comparison 1 Iron therapy versus placebo or no iron therapy, Outcome 4 Haemoglobin levels after treatment post‐op (g/dL).
Figuras y tablas -
Analysis 1.4

Comparison 1 Iron therapy versus placebo or no iron therapy, Outcome 4 Haemoglobin levels after treatment post‐op (g/dL).

Ir a la figura de la revisiónAbrir en una pestaña nueva

Comparison 2 Iron therapy: Intravenous versus oral administration, Outcome 1 Haemoglobin level pre‐treatment (g/dL).
Figuras y tablas -
Analysis 2.1

Comparison 2 Iron therapy: Intravenous versus oral administration, Outcome 1 Haemoglobin level pre‐treatment (g/dL).

Ir a la figura de la revisiónAbrir en una pestaña nueva

Comparison 2 Iron therapy: Intravenous versus oral administration, Outcome 2 Haemoglobin level post‐treatment pre‐op (g/dL).
Figuras y tablas -
Analysis 2.2

Comparison 2 Iron therapy: Intravenous versus oral administration, Outcome 2 Haemoglobin level post‐treatment pre‐op (g/dL).

Ir a la figura de la revisiónAbrir en una pestaña nueva

Comparison 2 Iron therapy: Intravenous versus oral administration, Outcome 3 Ferritin level pre‐treatment (ɥg/L).
Figuras y tablas -
Analysis 2.3

Comparison 2 Iron therapy: Intravenous versus oral administration, Outcome 3 Ferritin level pre‐treatment (ɥg/L).

Ir a la figura de la revisiónAbrir en una pestaña nueva

Comparison 2 Iron therapy: Intravenous versus oral administration, Outcome 4 Ferritin level post‐treatment (ɥg/L).
Figuras y tablas -
Analysis 2.4

Comparison 2 Iron therapy: Intravenous versus oral administration, Outcome 4 Ferritin level post‐treatment (ɥg/L).

Ir a la figura de la revisiónAbrir en una pestaña nueva
Summary of findings for the main comparison. Iron therapy versus placebo or no iron therapy for pre‐operative anaemia

Iron therapy versus placebo or no iron therapy for pre‐operative anaemia

Patient or population: Patients with pre‐operative anaemia
Settings: Major surgery
Intervention: Iron therapy versus placebo or no iron therapy

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Control

Iron therapy

Proportion of patients who received a blood transfusion

635 per 1000

356 per 1000
(171 to 749)

RR 0.56
(0.27 to 1.18)

38
(2 studies)

⊕⊕⊝⊝
low1

Amount of blood transfused per patient (in units)

Data from two small studies could not be combined as they were skewed and reported as medians and ranges. One RCT in 18 people reported a difference in medians of 0 (interquartile range: 1) with iron therapy. Another RCT in 20 people reported a median difference of 1 unit with iron therapy (range 0 to 2).

‐

38
(2 studies)

⊕⊕⊝⊝
low1

It is not possible to combine the data because they are skewed. These are the raw data.

Post‐operative mortality

‐

‐

‐

‐

‐

This outcome was not reported in either of the two studies available.

Post‐operative morbidity

‐

‐

‐

‐

‐

This outcome was not reported in either of the two studies available.

Any validated measure of quality of life

‐

‐

‐

‐

‐

This outcome was not reported in either of the two studies available.

Haemoglobin levels at end of treatment pre‐op (g/dL)

mean 11.9 g/dL (SD 2.6)

mean 11.2 g/d L(SD 1.95)

The mean haemoglobin levels at end of treatment pre‐op (g/dl) in the intervention groups was 0.7 g/dL lower
(2.82 lower to 1.42 higher)

18
(1 study)

⊕⊕⊝⊝
low2

Data from one study; the raw data are presented.

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio; MD: mean difference; g/dL: grams per decilitre of blood.

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Only two small randomised control trials and a subset of anaemic patients resulting in a very small number of participants.
2 Only one study with a small number of participants available.

Figuras y tablas -
Summary of findings for the main comparison. Iron therapy versus placebo or no iron therapy for pre‐operative anaemia
Ir a la tabla de la revisión
Summary of findings 2. Iron therapy: Intravenous versus oral administration for pre‐operative anaemia

Iron therapy: Intravenous versus oral administration for pre‐operative anaemia

Patient or population: Patients with pre‐operative anaemia
Settings: Major surgery
Intervention: Iron therapy: Intravenous versus oral administration

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Oral iron therapy

Intravenous iron therapy

Proportion of patients who received a blood transfusion

‐

‐

‐

‐

‐

This outcome was not reported in the one study available.

Amount of blood transfused per patient (in units)

‐

‐

‐

‐

‐

This outcome was not reported in the one study available.

Post‐operative mortality

‐

‐

‐

‐

‐

This outcome was not reported in the one study available.

Post‐operative morbidity

‐

‐

‐

‐

‐

This outcome was not reported in the one study available.

Any validated measure of quality of life

‐

‐

‐

‐

‐

This outcome was not reported in the one study available.

Haemoglobin levels at end of treatment pre‐op (g/dL)

mean 8.6 g/dL (SD 1.4)

mean 10.5 g/dL (SD 1.4)

The mean haemoglobin levels at end of treatment pre‐op (g/dl) in the intravenous group was
1.9 g/dL higher
(1.16 to 2.64 higher)

56
(1 study)

⊕⊕⊝⊝
low1,2

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
g/dL: grams per decilitre of blood.

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Study excluded those with less than 80% compliance with therapy and compliance was lower in the oral administration group.
2 Only one study with a small number of participants.

Figuras y tablas -
Summary of findings 2. Iron therapy: Intravenous versus oral administration for pre‐operative anaemia
Ir a la tabla de la revisión
Comparison 1. Iron therapy versus placebo or no iron therapy

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Proportion of patients who received a blood transfusion Show forest plot

2

38

Risk Ratio (M‐H, Fixed, 95% CI)

0.56 [0.27, 1.18]

2 Haemoglobin levels pre‐treatment (g/dL) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

3 Haemoglobin levels at end of treatment pre‐op (g/dL) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

4 Haemoglobin levels after treatment post‐op (g/dL) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected
Figuras y tablas -
Comparison 1. Iron therapy versus placebo or no iron therapy
Ir a la tabla de la revisión
Comparison 2. Iron therapy: Intravenous versus oral administration

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Haemoglobin level pre‐treatment (g/dL) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

2 Haemoglobin level post‐treatment pre‐op (g/dL) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

3 Ferritin level pre‐treatment (ɥg/L) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

4 Ferritin level post‐treatment (ɥg/L) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Subtotals only
Figuras y tablas -
Comparison 2. Iron therapy: Intravenous versus oral administration
Ir a la tabla de la revisión